Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 3132

1.

Clinicopathologic Characteristics of HER2-positive Pure Mucinous Carcinoma of the Breast.

Jang Y, Jung H, Kim HN, Seo Y, Alsharif E, Nam SJ, Kim SW, Lee JE, Park YH, Cho EY, Cho SY.

J Pathol Transl Med. 2019 Nov 13. doi: 10.4132/jptm.2019.10.24. [Epub ahead of print]

PMID:
31718120
2.

G3BP1 Depletion Increases Radiosensitisation by Inducing Oxidative Stress in Response to DNA Damage.

Cho E, Than TT, Kim SH, Park ER, Kim MY, Lee KH, Shin HJ.

Anticancer Res. 2019 Nov;39(11):6087-6095. doi: 10.21873/anticanres.13816.

PMID:
31704836
3.

Comparison of single minimum dose administration of dexmedetomidine and midazolam for prevention of emergence delirium in children: a randomized controlled trial.

Cho EA, Cha YB, Shim JG, Ahn JH, Lee SH, Ryu KH.

J Anesth. 2019 Nov 7. doi: 10.1007/s00540-019-02705-6. [Epub ahead of print]

PMID:
31701308
4.

Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study.

Yoon JS, Sinn DH, Lee JH, Kim HY, Lee CH, Kim SW, Lee HY, Nam JY, Chang Y, Lee YB, Cho EJ, Yu SJ, Kim HC, Chung JW, Kim YJ, Yoon JH.

Cancers (Basel). 2019 Nov 4;11(11). pii: E1721. doi: 10.3390/cancers11111721.

5.

Different parental origins of supernumerary X chromosomes in brothers with Klinefelter syndrome: A case report.

Kim SH, Park MJ, Cho EH, Kim S, Yoo SJ.

Medicine (Baltimore). 2019 Nov;98(44):e17838. doi: 10.1097/MD.0000000000017838.

6.

Serum FAM19A5 in neuromyelitis optica spectrum disorders: Can it be a new biomarker representing clinical status?

Lee HL, Seok HY, Ryu HW, Cho EB, Kim BC, Kim BJ, Min JH, Seok JM, Shin HY, Kang SY, Kwon OH, Lee SS, Oh J, Sohn EH, Huh SY, Cho JY, Seong JY, Kim BJ.

Mult Scler. 2019 Nov 4:1352458519885489. doi: 10.1177/1352458519885489. [Epub ahead of print]

PMID:
31680620
7.

Anion Extraction-Induced Polymorph Control of Transition Metal Dichalcogenides.

Nam DH, Kim JY, Kang S, Joo W, Lee SY, Seo H, Kim HG, Ahn IK, Lee GB, Choi M, Cho E, Kim M, Nam KT, Han S, Joo YC.

Nano Lett. 2019 Nov 6. doi: 10.1021/acs.nanolett.9b03240. [Epub ahead of print]

PMID:
31671269
8.

Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis.

Kavouridis VK, Boaro A, Dorr J, Cho EY, Iorgulescu JB, Reardon DA, Arnaout O, Smith TR.

J Neurosurg. 2019 Oct 25:1-11. doi: 10.3171/2019.6.JNS19972. [Epub ahead of print]

PMID:
31653812
9.

Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study.

Jeon MY, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Lee JH, Yu SJ, Kim YJ, Yoon JH, Cho EJ, Kim SU.

Gut Liver. 2019 Oct 25. doi: 10.5009/gnl19111. [Epub ahead of print]

10.
11.

A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-line Treatment for EGFR-mutation Positive NSCLC Patients.

Scagliotti G, Moro-Sibilot D, Kollmeier J, Favaretto A, Cho EK, Grosch H, Kimmich M, Girard N, Tsai CM, Hsia TC, Brighenti M, Schumann C, Wang XA, Wijayawardana SR, Gruver AM, Wallin J, Mansouri K, Wacheck V, Chang GC.

J Thorac Oncol. 2019 Oct 14. pii: S1556-0864(19)33530-0. doi: 10.1016/j.jtho.2019.10.003. [Epub ahead of print]

PMID:
31622732
12.

Electrostatic Potential Optimized Molecular Models for Molecular Simulations: CO, CO2, COS, H2S, N2, N2O, and SO2.

Cho EH, Lin LC.

J Chem Theory Comput. 2019 Nov 12;15(11):6323-6332. doi: 10.1021/acs.jctc.9b00653. Epub 2019 Oct 30.

PMID:
31618577
13.

The effect of coniferaldehyde on neurite outgrowth in neuroblastoma Neuro2a cells.

Jeon J, Kwon H, Cho E, Kim KS, Yun J, Lee YC, Kim DH.

Neurochem Int. 2019 Dec;131:104579. doi: 10.1016/j.neuint.2019.104579. Epub 2019 Oct 12.

PMID:
31614166
14.

Isolation of Crude Oil Peaks Differing by m/z ∼0.1 via Tandem Mass Spectrometry Using a Cyclic Ion Mobility-Mass Spectrometer.

Cho E, Riches E, Palmer M, Giles K, Ujma J, Kim S.

Anal Chem. 2019 Oct 29. doi: 10.1021/acs.analchem.9b02255. [Epub ahead of print]

PMID:
31613096
15.

'Sirim' (Cold) Pain as a Common Symptom in Korean Patients with Clinically Suspected Small-Fiber Neuropathy.

Cho EB, Seok JM, Min JH, Suh BC, Park KJ, Kim BJ.

J Clin Neurol. 2019 Oct;15(4):480-487. doi: 10.3988/jcn.2019.15.4.480.

16.

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis.

Kim DJ, Cho EJ, Yu KS, Jang IJ, Yoon JH, Park T, Cho JY.

Cancers (Basel). 2019 Oct 6;11(10). pii: E1497. doi: 10.3390/cancers11101497.

17.

Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study.

Ahn MJ, Han JY, Lee KH, Kim SW, Kim DW, Lee YG, Cho EK, Kim JH, Lee GW, Lee JS, Min YJ, Kim JS, Lee SS, Kim HR, Hong MH, Ahn JS, Sun JM, Kim HT, Lee DH, Kim S, Cho BC.

Lancet Oncol. 2019 Oct 3. pii: S1470-2045(19)30504-2. doi: 10.1016/S1470-2045(19)30504-2. [Epub ahead of print]

PMID:
31587882
18.

A novel therapeutic anti‑CD55 monoclonal antibody inhibits the proliferation and metastasis of colorectal cancer cells.

Dho SH, Cho EH, Lee JY, Lee SY, Jung SH, Kim LK, Lim JC.

Oncol Rep. 2019 Dec;42(6):2686-2693. doi: 10.3892/or.2019.7337. Epub 2019 Sep 26.

PMID:
31578581
19.
20.

Subtraction Images From Portal Venous Phase Gadoxetic Acid-Enhanced MRI for Observing Washout and Enhancing Capsule Features in LI-RADS Version 2018.

Chung JW, Yu JS, Choi JM, Cho ES, Kim JH, Chung JJ.

AJR Am J Roentgenol. 2019 Oct 1:1-9. doi: 10.2214/AJR.18.20797. [Epub ahead of print]

PMID:
31573851
21.

Doxorubicin conjugated AuNP/biopolymer composites facilitate cell cycle regulation and exhibit superior tumor suppression potential in KRAS mutant colorectal cancer.

Hung WH, Zheng JH, Lee KC, Cho EC.

J Biotechnol. 2019 Dec 20;306:149-158. doi: 10.1016/j.jbiotec.2019.09.015. Epub 2019 Sep 27.

PMID:
31568802
22.

Appropriate Timing of Early Postoperative Botulinum Toxin Type A Injection for Thyroidectomy Scar Management: A Split-Scar Study.

An MK, Cho EB, Park EJ, Kim KH, Kim LS, Kim KJ.

Plast Reconstr Surg. 2019 Oct;144(4):659e-668e. doi: 10.1097/PRS.0000000000006064.

PMID:
31568312
23.

Clinical Features and Outcomes of Community-Acquired Late-Onset Sepsis: Focusing on Group B Streptococcus and Escherichia coli.

Yun KW, Park SH, Cho EY, Lee H.

Pediatr Int. 2019 Sep 27. doi: 10.1111/ped.14012. [Epub ahead of print]

PMID:
31560155
24.

FAM19A5 Expression During Embryogenesis and in the Adult Traumatic Brain of FAM19A5-LacZ Knock-in Mice.

Shahapal A, Cho EB, Yong HJ, Jeong I, Kwak H, Lee JK, Kim W, Kim B, Park HC, Lee WS, Kim H, Hwang JI, Seong JY.

Front Neurosci. 2019 Aug 30;13:917. doi: 10.3389/fnins.2019.00917. eCollection 2019.

25.

PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption.

Cho E, Chen Z, Lee J, Lee S, Lee TH.

Molecules. 2019 Sep 14;24(18). pii: E3346. doi: 10.3390/molecules24183346.

26.

Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B.

Yoo JJ, Yu SJ, Lee B, Cho EJ, Lee JH, Kim SG, Kim YJ, Kim YS, Yoon JH.

Gut Liver. 2019 Sep 20. doi: 10.5009/gnl19112. [Epub ahead of print]

27.

Prognosis of surgical hernia repair in cirrhotic patients with refractory ascites.

Kim SW, Kim MA, Chang Y, Lee HY, Yoon JS, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Park KJ, Kim YJ.

Hernia. 2019 Sep 11. doi: 10.1007/s10029-019-02043-2. [Epub ahead of print]

PMID:
31512088
28.

The Effect of Perioperative Pregabalin on Pain after Arthroscopic Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial.

Cho EA, Kim N, Lee B, Song J, Choi YS.

J Clin Med. 2019 Sep 10;8(9). pii: E1426. doi: 10.3390/jcm8091426.

29.

Botulinum toxin type A suppresses pro-fibrotic effects via the JNK signaling pathway in hypertrophic scar fibroblasts.

Park GS, An MK, Yoon JH, Park SS, Koh SH, Mauro TM, Cho EB, Park EJ, Kim KH, Kim KJ.

Arch Dermatol Res. 2019 Dec;311(10):807-814. doi: 10.1007/s00403-019-01975-0. Epub 2019 Sep 9.

PMID:
31501922
30.

CYP1B1 prevents proteasome-mediated XIAP degradation by inducing PKCε activation and phosphorylation of XIAP.

Baek HS, Kwon YJ, Ye DJ, Cho E, Kwon TU, Chun YJ.

Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118553. doi: 10.1016/j.bbamcr.2019.118553. Epub 2019 Sep 4.

PMID:
31493422
31.

Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.

Chun HS, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Lee CH, Lee YB, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Lee JH, Kim SU.

Eur J Gastroenterol Hepatol. 2019 Sep 3. doi: 10.1097/MEG.0000000000001512. [Epub ahead of print]

PMID:
31490415
32.

Clinicopathological differentiation between Pityrosporum folliculitis and acneiform eruption.

An MK, Hong EH, Cho EB, Park EJ, Kim KH, Kim KJ.

J Dermatol. 2019 Nov;46(11):978-984. doi: 10.1111/1346-8138.15070. Epub 2019 Sep 5.

PMID:
31489692
33.

Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening.

Kim M, Mun H, Sung CO, Cho EJ, Jeon HJ, Chun SM, Jung DJ, Shin TH, Jeong GS, Kim DK, Choi EK, Jeong SY, Taylor AM, Jain S, Meyerson M, Jang SJ.

Nat Commun. 2019 Sep 5;10(1):3991. doi: 10.1038/s41467-019-11867-6.

34.

Quantitative analysis of fetal magnetic resonance phantoms and recommendations for an anthropomorphic motion phantom.

Shulman M, Cho E, Aasi B, Cheng J, Nithiyanantham S, Waddell N, Sussman D.

MAGMA. 2019 Sep 5. doi: 10.1007/s10334-019-00775-x. [Epub ahead of print] Review.

PMID:
31487004
35.

Digestibility of phosphorous in cereals and co-products for animal feed.

Park S, Cho E, Chung H, Cho K, Sa S, Balasubramanian B, Choi T, Jeong Y.

Saudi J Biol Sci. 2019 Feb;26(2):373-377. doi: 10.1016/j.sjbs.2018.12.003. Epub 2018 Dec 6.

36.

Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study.

Chang Y, Cho Y, Lee JH, Lee YB, Cho EJ, Yu SJ, Sinn DH, Kim BH, Kim SH, Yi NJ, Lee KW, Kim JM, Park JW, Kim YJ, Yoon JH, Joh JW, Suh KS.

Cancers (Basel). 2019 Sep 3;11(9). pii: E1295. doi: 10.3390/cancers11091295.

37.

Application of single-step genomic evaluation using social genetic effect model for growth in pig.

Hong JK, Kim YS, Cho KH, Lee DH, Min YJ, Cho ES.

Asian-Australas J Anim Sci. 2019 Dec;32(12):1836-1843. doi: 10.5713/ajas.19.0182. Epub 2019 Aug 26.

38.

Order-of-Magnitude, Broadband-Enhanced Light Emission from Quantum Dots Assembled in Multiscale Phase-Separated Block Copolymers.

Kim GY, Kim S, Choi J, Kim M, Lim H, Nam TW, Choi W, Cho EN, Han HJ, Lee C, Kim JC, Jeong HY, Choi SY, Jang MS, Jeon DY, Jung YS.

Nano Lett. 2019 Oct 9;19(10):6827-6838. doi: 10.1021/acs.nanolett.9b01941. Epub 2019 Sep 6.

PMID:
31476862
39.

A Review of Hepatocellular Carcinoma in Elderly Patients Focused on Management and Outcomes.

Cho E, Cho HA, Jun CH, Kim HJ, Cho SB, Choi SK.

In Vivo. 2019 Sep-Oct;33(5):1411-1420. doi: 10.21873/invivo.11618. Review.

40.

Newly Discovered Micropeptide Regulators of SERCA Form Oligomers but Bind to the Pump as Monomers.

Singh DR, Dalton MP, Cho EE, Pribadi MP, Zak TJ, Šeflová J, Makarewich CA, Olson EN, Robia SL.

J Mol Biol. 2019 Aug 23. pii: S0022-2836(19)30499-1. doi: 10.1016/j.jmb.2019.07.037. [Epub ahead of print]

PMID:
31449798
41.

Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial.

Kim DW, Lee DH, Han JY, Lee J, Cho BC, Kang JH, Lee KH, Cho EK, Kim JS, Min YJ, Cho JY, An HJ, Kim HG, Lee KH, Kim BS, Jang IJ, Yoon S, Han O, Noh YS, Hong KY, Park K.

Lung Cancer. 2019 Sep;135:66-72. doi: 10.1016/j.lungcan.2019.07.007. Epub 2019 Jul 9.

PMID:
31447004
42.

Access to Multifunctionalized Benzofurans by Aryl Nickelation of Alkynes: Efficient Synthesis of the Anti-Arrhythmic Drug Amiodarone.

Iqbal N, Iqbal N, Maiti D, Cho EJ.

Angew Chem Int Ed Engl. 2019 Oct 28;58(44):15808-15812. doi: 10.1002/anie.201909015. Epub 2019 Sep 20.

PMID:
31441180
43.

Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer.

Gray JE, Okamoto I, Sriuranpong V, Vansteenkiste J, Imamura F, Lee JS, Pang YK, Cobo M, Kasahara K, Cheng Y, Nogami N, Cho EK, Su WC, Zhang G, Huang X, Li-Sucholeiki X, Lentrichia B, Dearden S, Jenkins S, Saggese M, Rukazenkov Y, Ramalingam SS.

Clin Cancer Res. 2019 Nov 15;25(22):6644-6652. doi: 10.1158/1078-0432.CCR-19-1126. Epub 2019 Aug 22.

PMID:
31439584
44.

Examining Sources and Mechanisms of Reading Comprehension Difficulties: Comparing English Learners and Non-English Learners within the Simple View of Reading.

Cho E, Capin P, Roberts G, Roberts GJ, Vaughn S.

J Educ Psychol. 2019 Aug;111(6):982-1000. doi: 10.1037/edu0000332. Epub 2019 Jan 17.

45.

Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.

Kim KY, Yoon M, Cho Y, Lee KH, Park S, Lee SR, Choi SY, Lee D, Yang C, Cho EH, Jeon SD, Kim SH, Kim C, Kim MG.

J Exp Clin Cancer Res. 2019 Aug 19;38(1):363. doi: 10.1186/s13046-019-1373-y.

46.

Publisher Correction: Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality.

Lee YB, Nam JY, Lee JH, Chang Y, Cho H, Cho YY, Cho EJ, Yu SJ, Kim HY, Lee DH, Lee JM, Hwang SG, Kim YJ, Yoon JH.

Sci Rep. 2019 Aug 16;9(1):12146. doi: 10.1038/s41598-019-48367-y.

47.

A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer.

Cho E, Park IJ, Yeom SS, Hong SM, Lee JB, Kim YW, Kim MJ, Lim HM, Lim SB, Yu CS, Kim JC.

Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):834-842. doi: 10.1016/j.ijrobp.2019.07.058. Epub 2019 Aug 13.

PMID:
31419511
48.

Clinical relevance of TNM staging system according to breast cancer subtypes.

Park YH, Lee SJ, Cho EY, La Choi Y, Lee JE, Nam SJ, Yang JH, Shin JH, Ko EY, Han BK, Ahn JS, Im YH.

Ann Oncol. 2019 Aug 13. pii: mdz223. doi: 10.1093/annonc/mdz223. [Epub ahead of print] No abstract available.

PMID:
31408085
49.

Gluten intake and risk of psoriasis, psoriatic arthritis and atopic dermatitis among US women.

Drucker AM, Qureshi AA, Thompson JM, Li T, Cho E.

J Am Acad Dermatol. 2019 Aug 9. pii: S0190-9622(19)32549-6. doi: 10.1016/j.jaad.2019.08.007. [Epub ahead of print]

PMID:
31404570
50.

Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes.

Cho E, Islam SMBU, Jiang F, Park JE, Lee B, Kim ND, Hwang TH.

Cancer Res Treat. 2019 Aug 6. doi: 10.4143/crt.2019.161. [Epub ahead of print]

Supplemental Content

Support Center